Gilead Sciences
GILD · NASDAQ
Bulios Fair Price
$138.78
3.4% downside
Preț actual
$143.72
Potrivit Bulios Fair Price, acțiunile GILD se tranzacționează în prezent aproape de valoarea lor justă. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Gilead Sciences, Inc. (GILD) is an American biopharmaceutical company specializing in research, development, and manufacturing of pharmaceuticals in the field of infectious diseases, viral diseases, and chronic conditions, such as HIV/AIDS, hepatitis C, hepatitis B, and more. The company is renowned for its innovative treatment approaches and drugs that have a significant impact on improving the quality of life for patients worldwide. Gilead Sciences is actively engaged in research and collaborates with academic institutions and healthcare organizations to discover new therapies and medications. With successful products and a strong research background, Gilead Sciences, Inc. has the potential for further innovations and expanding its pharmaceutical portfolio. Investing in Gilead Sciences, Inc. (GILD) shares may present an interesting choice for investors who follow the pharmaceutical sector and seek a company with a track record of successful products and commitment to combating serious diseases.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Daniel O'Day
Employees
17,000
Headquarters
Foster City
Evenimente viitoare
Ex-Dividend
Ex-dividend date
Dividend Payment
Data plății
Earnings
Upcoming earnings report